
WhiteOak Capital Pharma and Healthcare Fund-Reg (G)
Equity · Sectoral
22.77%
Last 1 year
- Exit Load
- 0.00%
- Expense Ratio
- 2.72%
- Min. AmountMin. SIP Amount
- ₹100
- Min. Lump SumMin. Lump sum
- ₹500
Historical View
Return Calculator
- Invested Amount
- ₹9,00,000
- Calculated AmountCurrent Value
- ₹9,00,000
- IRR
- 0.000%
- Absolute Gain
- +₹0 (+0.0%)
Returns & Rankings
Category: Equity Sectoral


63 ProductsEquity Sectoral Funds


63 ProductsWealthy Score
Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.
- 1Y Returns
- 22.8%
- Alpha
- 16.5
Holding Analysis
Equity/Debt/Cash Split
- Equity90.6%
- Debt9.4%
Market Cap Weightage
- Large Cap33.8%
- Small Cap31.2%
- Mid Cap25.6%
- Others9.4%
Sector allocation
- Healthcare85.4%
- Debt5.3%
- Materials5.3%
- Cash4.1%
Top 10 HoldingsTop Holdings
| Stocks | Sector | Percentage |
|---|---|---|
| Divi's Lab. | Pharmaceuticals | 8.87% |
| Sun Pharma.Inds. | Pharmaceuticals | 6.68% |
| Torrent Pharma. | Pharmaceuticals | 5.87% |
| Laurus Labs | Pharmaceuticals | 5.59% |
| C C I | Debt Others | 4.62% |
| Apollo Hospitals | Healthcare | 3.73% |
| Zydus Lifesci. | Pharmaceuticals | 3.1% |
| Sai Life | Pharmaceuticals | 3.02% |
| Ipca Labs. | Pharmaceuticals | 2.91% |
| Mankind Pharma | Pharmaceuticals | 2.5% |
- 8.87%
Divi's Lab.
Pharmaceuticals
- 6.68%
Sun Pharma.Inds.
Pharmaceuticals
- 5.87%
Torrent Pharma.
Pharmaceuticals
- 5.59%
Laurus Labs
Pharmaceuticals
- 4.62%
C C I
Debt Others
Top Funds in the Category
| Fund Name | Rating | Category | 1Y | 3Y |
|---|---|---|---|---|
| — | Equity | 16.23% | 29.6% | |
| — | Equity | 28.41% | 28.89% | |
| — | Equity | 23.71% | 23.26% | |
| — | Equity | 20.06% | 21.85% | |
| — | Equity | 24.28% | 21.75% |
Peer Comparison
WhiteOak Capital Pharma and Healthcare Fund-Reg (G)
- 1 Y Return
- 22.77%
- 3 Y Return
- —
- 5 Y Return
- —
Nifty 50
- 1 Y Return
- -2.32%
- 3 Y Return
- 9.41%
- 5 Y Return
- 8.00%
Investment Objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.
Fund Management

Ramesh Mantri
Over 20 years' experience in financial market: 1. WhiteOak Capital Asset Management Limited (December 21, 2021 - till now) 2. White Oak Capital Management (June 2017 to December 21, 2021) 3. Ashoka Capital Advisers (February 2013- May 2017) 4. Smith Management-Mumbai Office (September 2005 - January 2013)
Riskometer
- Risk Score
- 6
- Risk Level
- Very High
Advanced Ratios
- AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
- 16.50
- BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
- 0.66
- SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
- 0.87
- SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
- 16.02
- TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
- 0.10
- P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
- 54.56
Tax Implication
STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year
FAQs
WhiteOak Capital Pharma and Healthcare Fund-Reg – Regular Plan - Growth was launched 2 years ago and has delivered annualised returns (CAGR) of 22.18% since inception. Here is how it compares with the category average:
Period Fund Category average 1 Year 22.77% 6.93% Since Inception 22.18% Returns as on 18 Nov 2026. 1-year returns are absolute; returns above 1 year are CAGR. Past performance may or may not be sustained in future.
The expense ratio of WhiteOak Capital Pharma and Healthcare Fund-Reg – Regular Plan - Growth is 2.72%. This is the annual fee for managing and operating the fund. It is adjusted in the daily NAV, so the returns you see are already net of this cost.
WhiteOak Capital Pharma and Healthcare Fund-Reg is rated Very High risk on the SEBI riskometer. The riskometer has six levels, from Low to Very High, and fund houses review it every month.
You can start an SIP in WhiteOak Capital Pharma and Healthcare Fund-Reg with ₹100 a month, or invest a lump sum of ₹500. Additional investments start at ₹500.
WhiteOak Capital Pharma and Healthcare Fund-Reg has no exit load.
No, WhiteOak Capital Pharma and Healthcare Fund-Reg has no lock-in period, so you can redeem anytime. An exit load may apply on early redemption.
WhiteOak Capital Pharma and Healthcare Fund-Reg manages assets (AUM) of approximately ₹964 Cr.
As on 31 Oct 2026, WhiteOak Capital Pharma and Healthcare Fund-Reg holds 65 securities. These are its top 10 holdings:
Company % of portfolio Divi's Lab. 8.87% Sun Pharma.Inds. 6.68% Torrent Pharma. 5.87% Laurus Labs 5.59% C C I 4.62% Apollo Hospitals 3.73% Zydus Lifesci. 3.10% Sai Life 3.02% Ipca Labs. 2.91% Mankind Pharma 2.50% As on 31 Oct 2026, these are the fund's largest sector allocations:
Sector % of portfolio Healthcare 85.36% Debt 5.31% Materials 5.27% Cash 4.06% If you invested through a Wealthy partner, you can place a redemption request in the Wealthy app, or ask your partner to do it for you. If you invested elsewhere, you can redeem through the WhiteOak Mutual Fund website, MF Central or CAMS. The money is credited to your registered bank account, usually within a few working days. Exit load and capital gains tax may apply.











